Caden Leung

Mr. Caden Leung

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 August 2025 in Brain Sciences
Verified
Journal Article
Open access
PDF file
Caden LeungCaden Leung
Caden Leung
Kabirullah LutfyKabirullah Lutfy
Kabirullah Lutfy
Obesity has become a major public health crisis and serves as an underlying condition for other chronic metabolic diseases. The dysregulation of the inhibitory and regulatory mechanisms of the mesolimbic dopamine system, particularly dopamine D2 receptors (D2Rs), plays a critical role in driving excessive food consumption and compulsive eating habits. Based on the current literature, chronic consumption of high-fat foods elicits hedonic sensations and has the potential to downregulate and desensitize D2Rs, impairing their signaling and inhibitory action. This impairment thereby alters the downstream signaling of the D2Rs, involving the inhibition of adenylyl cyclase and the associated cascade. Although individual components of this proposed pathway have been studied, a comprehensive synthesis has not been established. This review aims to explore the relationship between D2R downregulation and desensitization and their effects on the downstream signaling cascade. We hypothesize that alterations in this pathway may lead to the dysregulation of the expression of orexigenic and anorexigenic neuropeptides, contributing to binge-eating behaviors.

8 July 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
AJAneesha Janbandhu
Aneesha Janbandhu
Caden LeungCaden Leung
Caden Leung
EWEvelyn Wu
Evelyn Wu
ATAidan Tom
Aidan Tom
TCTobias D Chang
Tobias D Chang
Kabirullah LutfyKabirullah Lutfy
Kabirullah Lutfy
Background/Objectives: The rates of obesity and binge-eating disorder (BED) have increased markedly over the last few decades. The onset of these conditions has been attributed in part to the disruption of neural pathways that regulate food reward. Existing literature has identified the endogenous opioid system as an important mediator of pleasure and reinforcing behaviors associated with food intake. While the relationship between opioids and food intake has been studied extensively, how dysregulated opioid signaling contributes to compulsive eating still remains unclear. Therefore, the aim of this review is to analyze the role of opioid peptides and receptors, and their interactions with dopamine in hedonic feeding. Methods: We conducted a narrative review of preclinical and clinical trials, incorporating studies that were relevant to opioid-mediated feeding and food reward. Results: β-endorphins modulate the hedonic value of food, but their effects appear to be context-dependent. Enkephalins regulate motivational drive toward food, while nociceptin signaling preferentially promotes the consumption of palatable foods under binge-like conditions. Consistent with these findings, NOP antagonism reduces binge on a high fat diet (HFD) without affecting homeostatic eating patterns. Lastly, chronic mu opioid receptor (MOR) activation by palatable foods may induce neuroadaptive changes, including receptor desensitization, dopamine D2 receptor downregulation, and reward hypofunctionality, paralleling mechanisms associated with substance use disorders. Conclusions: Altered MOR signaling disrupts the hedonic and behavioral mechanisms that regulate feeding behavior. Pharmacological therapies targeting opioid and opioid-dopamine interactions may show promise for treating obesity and BED. However, additional research is still needed to clarify peptide-specific mechanisms, sex differences, and long-term neurobiological consequences of hedonic and compulsive eating.

13 July 2026 in Brain Sciences
Verified
Journal Article
Open access
PDF file
AJAneesha Janbandhu
Aneesha Janbandhu
Caden LeungCaden Leung
Caden Leung
EWEvelyn Wu
Evelyn Wu
ATAidan Tom
Aidan Tom
TCTobias D Chang
Tobias D Chang
Kabirullah LutfyKabirullah Lutfy
Kabirullah Lutfy
Background/Objectives: The rates of obesity and binge-eating disorder (BED) have increased markedly over the last few decades. The onset of these conditions has been associated in part with the disruption of neural pathways that regulate food reward. Existing literature has implicated the endogenous opioid system as an important mediator of pleasure and reinforcing behaviors associated with food intake. While the relationship between opioids and food intake has been studied extensively, how dysregulated opioid signaling contributes to compulsive eating still remains unclear. Therefore, the aim of this review is to analyze the role of opioid peptides and receptors, and their interactions with dopamine in hedonic feeding. Methods: We conducted a narrative review of preclinical and clinical trials, incorporating studies that were relevant to opioid-mediated feeding and food reward. Results: β-endorphins appear to modulate the hedonic value of food, but their effects appear to be context-dependent. Enkephalins may influence motivational drive toward food, while nociceptin signaling has been linked to the preferential consumption of palatable foods under binge-like conditions. Consistent with these findings, NOP antagonism has been reported to reduce binge-like intake of a high-fat diet (HFD) without affecting homeostatic eating patterns. Lastly, chronic mu-opioid receptor (MOP) activation by palatable foods may induce neuroadaptive changes, including receptor desensitization, dopamine D2 receptor downregulation, and reward hypofunctionality, which overlap with mechanisms associated with substance use disorders. Conclusions: Altered MOP signaling may disrupt the hedonic and behavioral mechanisms that regulate feeding behavior. Pharmacological therapies targeting opioid and opioid-dopamine interactions may show promise for treating obesity and BED. However, additional research is still needed to clarify peptide-specific mechanisms, sex differences, and long-term neurobiological consequences associated with hedonic and compulsive eating.